申请人:Warner-Lambert Company
公开号:US05491170A1
公开(公告)日:1996-02-13
.beta.-Carboxy sulfonyl compounds of the formula ##STR1## wherein R.sub.1 is aryl, R.sub.3 is hydrogen or alkyl, R.sub.3 and R.sub.4 are hydrogen or alkyl, Y is --O--, --S--, or --NR.sub.2 --, and R.sub.5 is alkyl or aryl are potent inhibitors of the enzyme acyl CoA:cholesterol acyltransferase (ACAT) and are thus useful for treating hypercholesterolemia and atherosclerosis.
公式为##STR1##的.beta.-羧基磺酰化合物,其中R.sub.1为芳基,R.sub.3为氢或烷基,R.sub.3和R.sub.4为氢或烷基,Y为--O--,--S--或--NR.sub.2--,R.sub.5为烷基或芳基,是酰基辅酶A:胆固醇酰基转移酶(ACAT)的有效抑制剂,因此可用于治疗高胆固醇血症和动脉硬化。